Hydrastine
From Self-sufficiency
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (February 2007) |
150px | |
Systematic (IUPAC) name | |
---|---|
6,7-dimethoxy-3-(6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one | |
Clinical data | |
Pregnancy category |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
CAS Number | 118-08-1 |
ATC code | none |
PubChem | CID 1309 |
Chemical data | |
Formula | C21H21NO6 |
Molar mass | 383.395[[Script error: No such module "String".]] |
Hydrastine is a natural alkaloid which was discovered in 1851 by Alfred P. Durand. By hydrolysis of hydrastine one receives Hydrastinine, which was patented by Bayer as a haemostatic drug during 1910s.
It is naturally present in Hydrastis canadensis (thus the name) and other plants of the ranunculaceae.
This pharmacology-related article is a stub. You can help ssf by expanding it. |
40px | This biochemistry article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from February 2007
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Alkaloids
- Dioxoloisoquinolines
- Phenol ethers
- Lactones
- Isobenzofurans
- Pharmacology stubs
- Biochemistry stubs
- 2Fix